Results 271 to 280 of about 311,335 (299)

Angiotensin-(1-7) as an antihypertensive, antifibrotic target

Current Hypertension Reports, 2008
Over the past two decades, enormous progress has been made in understanding the possible physiological significance of alternate renin-angiotensin system processing pathways and angiotensin fragments, such as angiotensin (Ang)-(1-7). Evidence from in vivo and ex vivo studies in humans and various animal models suggests a possible role for this ...
Michael J, Katovich, Justin L, Grobe, Mohan K, Raizada   +2 more
openaire   +2 more sources

Angiotensin-(1-7) and the Heart

2019
An underpinning of our current evolving concepts on the contributions of angiotensin peptides to cardiovascular disease resides in the discovery of biological actions of angiotensin-(1-7) as an intrinsic endogenous biotransformation factor counteracting angiotensin II actions.
Carlos M. Ferrario, Che Ping Cheng, Jasmina Varagic   +2 more
openaire   +1 more source

[Angiotensin (1-7) receptor].

Nihon rinsho. Japanese journal of clinical medicine, 2009
Mas, which was protooncogene, first detected in vivo by tumorigenic properties originating from rearrangement of its 5'-flanking region was identified as a functional receptor for angiotensin (1-7) and provide a clear molecular basis for the physiological actions of this biologically active peptide. Angiotensin (1-7) is mainly produced from angiotensin
Mitsuru, Ohishi, Hiromi, Rakugi
openaire   +1 more source

The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts

Kidney International Supplements, 2022
CARLOS M Ferrario, Leanne Groban, Xuming Sun   +2 more
exaly  

Angiotensin II/Angiotensin-(1–7)

2013
Patricia E. Gallagher, Alison L. Arter, Bhavani Krishnan, Maria A. Garcia-Espinosa, E. Ann Tallant   +4 more
openaire   +1 more source

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

Circulation Research, 2020
Mahmoud Gheblawi, Kaiming Wang, Anissa Viveiros   +2 more
exaly  

Angiotensin-(1-7)

2005
Debra I. Diz, Mark C. Chappell, E. Ann Tallant, Carlos M. Ferrario   +3 more
openaire   +1 more source

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation Research, 2020
Peng Zhang, Lihua Zhu, Jingjing Cai
exaly  

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Circulation, 2005
CARLOS M Ferrario, Mark C Chappell, David B Averill   +2 more
exaly  

Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent

Hypertension, 2020
Jan Wysocki, Minghao Ye, Pan Liu
exaly